Nectar Lifesciences Limited (NSE: NECLIFE), ISIN INE023H01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NECLIFE last traded at ₹10.20 (-0.29%), with a 52-week range of ₹9.20 to ₹22.49 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 51.84%, FIIs 0.58%, DIIs 3.54%, mutual funds 0.00%.
EquiSense Score (ECS): 35/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.